Texas Attorney General Sues Tylenol Makers Regarding Autism Spectrum Allegations

Texas Attorney General Ken Paxton is taking legal action against the producers of Tylenol, alleging the companies hid alleged dangers that the medication posed to pediatric cognitive development.

This legal action comes four weeks after President Donald Trump advocated an unproven link between taking Tylenol - referred to as paracetamol - during pregnancy and autism in children.

Paxton is taking legal action against Johnson & Johnson, which formerly manufactured the drug, the only pain reliever approved for pregnant women, and the current manufacturer, which now manufacturers it.

In a declaration, he stated they "misled consumers by gaining financially from discomfort and marketing drugs ignoring the potential hazards."

Kenvue asserts there is lacking scientific proof tying acetaminophen to autism.

"These corporations misled for generations, deliberately risking numerous people to line their pockets," Paxton, from the Republican party, said.

The company stated officially that it was "very worried by the dissemination of inaccurate information on the security of acetaminophen and the likely effects that could have on the health of US mothers and children."

On its website, Kenvue also stated it had "regularly reviewed the pertinent research and there is insufficient valid information that demonstrates a established connection between taking acetaminophen and autism spectrum disorder."

Groups representing medical professionals and health professionals share this view.

ACOG has said paracetamol - the main ingredient in acetaminophen - is one of the few options for women during pregnancy to manage discomfort and fever, which can present significant medical dangers if ignored.

"In over twenty years of research on the use of acetaminophen in gestation, not a single reputable study has conclusively proven that the consumption of acetaminophen in any period of pregnancy causes neurological conditions in young ones," the association commented.

The lawsuit mentions recent announcements from the previous government in claiming the drug is potentially dangerous.

In recent weeks, Trump caused concern from medical authorities when he told pregnant women to "struggle intensely" not to take acetaminophen when ill.

Federal regulators then released a statement that physicians should consider limiting the usage of Tylenol, while also stating that "a direct connection" between the medication and autism in children has not been established.

The Health Department head Kennedy, who oversees the Food and Drug Administration, had pledged in April to initiate "extensive scientific investigation" that would identify the cause of autism spectrum disorder in a short period.

But experts advised that discovering a single cause of autism - thought by researchers to be the result of a complex mix of genetic and environmental factors - would prove challenging.

Autism spectrum disorder is a category of enduring cognitive variation and condition that impacts how people perceive and relate to the surroundings, and is identified using doctors' observations.

In his lawsuit, the attorney general - who supports Trump who is seeking the Senate - alleges Kenvue and Johnson & Johnson "deliberately disregarded and tried to quiet the evidence" around paracetamol and autism spectrum disorder.

This legal action seeks to make the corporations "remove any commercial messaging" that states Tylenol is reliable for pregnant women.

The court case echoes the grievances of a group of mothers and fathers of minors with autism spectrum disorder and attention deficit hyperactivity disorder who sued the manufacturers of acetaminophen in two years ago.

The court threw out the case, saying studies from the plaintiffs' authorities was inconclusive.